|
English
|
正體中文
|
简体中文
|
總筆數 :2856565
|
|
造訪人次 :
53437905
線上人數 :
782
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 260391-260400 / 2348973 (共234898頁)
<< < 26035 26036 26037 26038 26039 26040 26041 26042 26043 26044 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2006 |
Clinical Implications of Major Aortopulmonary Collateral Arteries in Patients With Right Isomerism
|
Wu M.-H.; Lue H.-C.; Chen C.-A.; Chiu S.-N.; Hsu J.-Y.;Wang J.-K.;Lin M.-T.;En-Ting Wu;Chiu S.-N.;Chen C.-A.;Lue H.-C.;Wu M.-H.; Hsu J.-Y.; Wang J.-K.; Lin M.-T.; EN-TING WU |
| 臺大學術典藏 |
2021-01-05T08:07:36Z |
Clinical Implications of Major Aortopulmonary Collateral Arteries in Patients With Right Isomerism
|
Chen C.-A.; Chiu S.-N.; Wu E.-T.; Lin M.-T.; Wang J.-K.; Hsu J.-Y.; Lue H.-C.; MEI-HWAN WU |
| 臺大學術典藏 |
2021-01-06T05:46:46Z |
Clinical Implications of Major Aortopulmonary Collateral Arteries in Patients With Right Isomerism
|
Hsu J.-Y.;Jou-Kou Wang;Lin M.-T.;Wu E.-T.;Chiu S.-N.;Chen C.-A.;Lue H.-C.;Wu M.-H.; Hsu J.-Y.; JOU-KOU WANG; Lin M.-T.; Wu E.-T.; Chiu S.-N.; Chen C.-A.; Lue H.-C.; Wu M.-H. |
| 國立臺灣大學 |
2006-01 |
Clinical implications of major aortopulmonary collateral arteries in patients with right isomerism.
|
Hsu, JY; Wang, JK; Lin, MT; Wu, ET; Chiu, SN; Chen, CA; Lue, HC; Wu, MH |
| 國立臺灣大學 |
2007 |
Clinical Implications of Minimal Residual Disease Monitoring by Quantitative Polymerase Chain Reaction in Acute Myeloid Leukemia Patients Bearing Nucleophosmin (Npm1) Mutations
|
周文堅; 唐季祿; 吳尚儒; 蔡偉; 姚明; 黃聖懿; 陳建源; 黃琦斐; 田蕙芬; CHOU, WEN-CHIEN; TANG, JIH-LUH; WU, SHANG-JU; TSAY, WOEI; YAO, MING; HUANG, SHANG-YI; CHEN, CHIEN-YUAN; HUANG, CHI-FEI; TIEN HWEI-FANG |
| 國立臺灣大學 |
2007-05 |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Chou, WC; Tang, JL; Wu, SJ; Tsay, W; Yao, M; Huang, SY; Huang, KC; Chen, CY; Huang, CF; Tien, HF |
| 臺大學術典藏 |
2007 |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Tang J.-L.; Chou W.-C.; SHANG-JU WU; Tsay W.; Yao M.; Huang S.-Y.; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:50Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Chou W.-C.; JIH-LUH TANG; Wu S.-J.; Tsay W.; Yao M.; Huang S.-Y.; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-14T03:09:13Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Chou W.-C.; Tang J.-L.; Wu S.-J.; Tsay W.; Yao M.; Huang S.-Y.; KUO-CHIN HUANG; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:47Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
WEN-CHIEN CHOU; Tang J.-L.; Wu S.-J.; Tsay W.; Yao M.; Huang S.-Y.; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
顯示項目 260391-260400 / 2348973 (共234898頁)
<< < 26035 26036 26037 26038 26039 26040 26041 26042 26043 26044 > >>
每頁顯示[10|25|50]項目
|
